Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome

被引:387
作者
Holtzman, DM
Santucci, D
Kilbridge, J
ChuaCouzens, J
Fontana, DJ
Daniels, SE
Johnson, RM
Chen, K
Sun, YL
Carlson, E
Alleva, E
Epstein, CJ
Mobley, WC
机构
[1] WASHINGTON UNIV, SCH MED, CTR STUDY NERVOUS SYST INJURY, ST LOUIS, MO 63110 USA
[2] IST REGINA ELENA, BEHAV PATHOPHYSIOL SECT, I-00161 ROME, ITALY
[3] ROCHE BIOSCI, INST PHARMACOL, DEPT NEUROBIOL, PALO ALTO, CA 94304 USA
[4] GENENTECH INC, DEPT NEUROSCI, San Francisco, CA 94080 USA
[5] UNIV CALIF SAN FRANCISCO, DEPT NEUROL, SAN FRANCISCO, CA 94143 USA
[6] UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA
[7] UNIV CALIF SAN FRANCISCO, PROGRAM NEUROSCI, SAN FRANCISCO, CA 94143 USA
关键词
D O I
10.1073/pnas.93.23.13333
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To study the pathogenesis of central nervous system abnormalities in Down syndrome (DS), we have analyzed a new genetic model of DS, the partial trisomy 16 (Ts65Dn) mouse. Ts65Dn mice have an extra copy of the distal aspect of mouse chromosome 16, a segment homologous to human chromosome 21 that contains much of the genetic material responsible for the DS phenotype. Ts65Dn mice show developmental delay during the postnatal period as well as abnormal behaviors in both young and adult animals that may be analogous to mental retardation. Though the Ts65Dn brain is normal on gross examination, there is age-related degeneration of septohippocampal cholinergic neurons and astrocytic hypertrophy, markers of the Alzheimer disease pathology that is present in elderly DS individuals. These findings suggest that Ts65Dn mice may be used to study certain developmental and degenerative abnormalities in the DS brain.
引用
收藏
页码:13333 / 13338
页数:6
相关论文
共 52 条
[1]   SHORT-TERM, MEDIUM-TERM, AND LONG-TERM EFFECTS OF PRENATAL OXAZEPAM ON NEUROBEHAVIOURAL DEVELOPMENT OF MICE [J].
ALLEVA, E ;
LAVIOLA, G ;
TIRELLI, E ;
BIGNAMI, G .
PSYCHOPHARMACOLOGY, 1985, 87 (04) :434-441
[2]   THE TRK FAMILY OF TYROSINE PROTEIN-KINASE RECEPTORS [J].
BARBACID, M ;
LAMBALLE, F ;
PULIDO, D ;
KLEIN, R .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :115-127
[3]  
CALAMANDREI G, 1996, IN PRESS BRAIN RES
[4]   ABNORMALITIES OF THE NUCLEUS BASALIS IN DOWNS-SYNDROME [J].
CASANOVA, MF ;
WALKER, LC ;
WHITEHOUSE, PJ ;
PRICE, DL .
ANNALS OF NEUROLOGY, 1985, 18 (03) :310-313
[5]  
CAVALIERI B, 1966, GEOMETRIA DEGLI INDI
[6]   REDUCED TRANSPORT OF [I-125] NERVE GROWTH-FACTOR BY CHOLINERGIC NEURONS AND DOWN-REGULATED TRKA EXPRESSION IN THE MEDIAL SEPTUM OF AGED RATS [J].
COOPER, JD ;
LINDHOLM, D ;
SOFRONIEW, MV .
NEUROSCIENCE, 1994, 62 (03) :625-629
[7]   Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: Altered behavior in the elevated plus maze and open field [J].
CoussonsRead, ME ;
Crnic, LS .
BEHAVIOR GENETICS, 1996, 26 (01) :7-13
[8]   DOWN SYNDROME, ALZHEIMERS-DISEASE AND THE TRISOMY-16 MOUSE [J].
COYLE, JT ;
OSTERGRANITE, ML ;
REEVES, RH ;
GEARHART, JD .
TRENDS IN NEUROSCIENCES, 1988, 11 (09) :390-394
[9]  
DAVISSON MT, 1993, SEGMENTAL TRISOMY MO, P117
[10]   NEUROPATHOLOGICAL CHANGES IN SCRAPIE AND ALZHEIMERS-DISEASE ARE ASSOCIATED WITH INCREASED EXPRESSION OF APOLIPOPROTEIN-E AND CATHEPSIN-D IN ASTROCYTES [J].
DIEDRICH, JF ;
MINNIGAN, H ;
CARP, RI ;
WHITAKER, JN ;
RACE, R ;
FREY, W ;
HAASE, AT .
JOURNAL OF VIROLOGY, 1991, 65 (09) :4759-4768